GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice
Journal of Peptide Science 23(12):845–854, 2017
A hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonist
ACS Chemical Biology 12(8):2107–2116, 2017
Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass
Molecular Metabolism 5(4):296-304, 2016
Neuromedin U inhibits food intake partly by inhibiting gastric emptying
Peptides 69:56–65, 2015
Synthesis and evaluation of novel lipidated neuromedin U analogs with increased stability and effects on food intake
Journal of Peptide Science 21(2):85–94, 2015
The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat
European Journal of Pharmacology 741:254-263, 2014
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Journal of Clinical Investigation 124(10):4473-4488, 2014
Liraglutide: short-lived effect on gastric emptying – long lasting effects on body weight
Diabetes Obesity & Metabolism 14(6):531–538, 2012